Study of the serological response after vaccination against tick-borne encephalitis in Sweden

Vaccine

Volumn 25, Issue 2, 2007, Pages 366-372

  Vene, Sirkka ^a,b   Haglund, Mats ^c   Lundkvist, Åke ^a,b   Lindquist, Lars ^c   Forsgren, Marianne ^c  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibody response; Human; Long term follow up; Neutralization test; TBE vaccination

Indexed keywords

FSME IMMUN; NEUTRALIZING ANTIBODY; TICK BORNE ENCEPHALITIS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DEVICE; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SEROLOGY; SWEDEN; TICK BORNE ENCEPHALITIS; TREATMENT FAILURE; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; VACCINATION; VIRAL VACCINES;

EID: 33845344014     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.07.026     Document Type: Article

References (50)

1. Dittman S., and Jilg W. Tick-borne encephalitis in the European region (1998), WHO regional office for Europe, Copenhagen, Denmark
2. Günther G., Haglund M., Lindquist L., Forsgren M., and Sköldenberg B. Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol 244 4 (1997) 230-238
3. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain 122 Pt 11 (1999) 2067-2078
4. Mickiene A., Laiskonis A., Günther G., Vene S., Lundkvist A., and Lindquist L. Tickborne encephalitis in an area of high endemicity in Lithuania: disease severity and long-term prognosis. Clin Infect Dis 35 6 (2002) 650-658
5. Duniewicz M., Mertenova J., Moravcova E., Jelinkova E., Holy M., Kulkova H., et al. Central european tick-borne encephalitis from 1969 to 1972 in central bohemia. Infection 3 4 (1975) 223-228 [Author's transl]
6. Falisevac J., and Beus I. Clinical manifestations of TBE in Croatia. In: Kunz C. (Ed). Tick-borne encephalitis, international symposium (1979), Facultas-Verlag, Wien 13-19
7. Krausler J. 23 years of TBE in the District of Neukirchen (Austria). In: Kunz C. (Ed). Tick-borne encephalitis, international symposium (1979), Facultas-Verlag, Wien 6-12
8. Radsel-Medvescek A, Marolt-Gomiscek M, Gajsek-Zima M. Clinical characteristics of patients with TBE treated at the University Medical Centre Hospital for Infectious Diseases in Ljubljana during the years 1974 and 1977. In: Vesenjak-Hirjan J, et al., editors. Arboviruses in the Mediterranean Countries. Zbl Bakt suppl 9. Stuttgart, New York: Gustav Fisher Verlag; 1980. p. 277-80.
9. Jezyna C., Zajac W., Ciesielski T., and Pancewicz S. Epidemiologic and clinical studies of patients with tick-borne encephalitis from northeastern Poland. Zentralbl Bakteriol Mikrobiol Hyg B 178 5/6 (1984) 510-521
10. Ackermann R., Kruger K., Roggendorf M., Rehse-Kupper B., Mortter M., Schneider M., et al. Spread of early-summer meningoencephalitis in the Federal Republic of Germany. Dtsch Med Wochenschr 111 24 (1986) 927-933
11. Wahlberg P., Saikku P., and Brummer-Korvenkontio M. Tick-borne viral encephalitis in Finland The clinical features of Kumlinge disease during 1959-1987. J Intern Med 225 3 (1989) 173-177
12. Holmgren E.B., and Forsgren M. Epidemiology of tick-borne encephalitis in Sweden 1956-1989: a study of 1116 cases. Scand J Infect Dis 22 3 (1990) 287-295
13. Köck T., Stunzner D., Freidl W., and Pierer K. Clinical aspects of early summer meningoencephalitis in Styria. Nervenarzt 63 4 (1992) 205-208
14. Tomazik J., Pikelj F., Schwartz B., et al. The clinical features of tick-borne encephalitis in Slovenia. A study of 492 cases in1994. Antibiot Monit 12 4/5 (1996) 115-120
15. Haglund M., and Günther G. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 21 Suppl 1 (2003) S11-S18
16. Heinz F.X., Kunz C., and Fauma H. Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation. J Med Virol 6 3 (1980) 213-221
17. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 Suppl 1 (2003) S50-S55
18. Bender A., Jager G., Scheuerer W., Feddersen B., Kaiser R., and Pfister H.W. Two severe cases of tick-borne encephalitis despite complete active vaccination-the significance of neutralizing antibodies. J Neurol 251 3 (2004) 353-354
19. Kunze U., Baumhackl U., Bretschneider R., Chmelik V., Grubeck-Loebenstein B., Haglund M., et al. The golden agers and tick-borne encephalitis. Conference report and position paper of the international scientific working group on tick-borne encephalitis. Wien Med Wochenschr 155 11/2 (2005) 289-294
20. Kunz C., Heinz F.X., and Hofmann H. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J Med Virol 6 2 (1980) 103-109
21. Kunz C., Hofmann H., and Dippe H. Early summer meningoencephalitis vaccination, a preventive medicine measure with high acceptance in Austria. Wien Med Wochenschr 141 12 (1991) 273-276
22. Holzmann H., Vorobyova M.S., Ladyzhenskaya I.P., Ferenczi E., Kundi M., Kunz C., et al. Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes. Vaccine 10 5 (1992) 345-349
23. Craig S.C., Pittman P.R., Lewis T.E., Rossi C.A., Henchal E.A., Kuschner R.A., et al. An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia. Am J Trop Med Hyg 61 6 (1999) 874-878
24. Demicheli V., Graves P., Pratt M., and Jefferson T. Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev 2 (2000) CD000977
25. Stephenson J.R., Lee J.M., Easterbrook L.M., Timofeev A.V., and Elbert L.B. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis. Vaccine 13 8 (1995) 743-746
26. Holzmann H., Kundi M., Stiasny K., Clement J., McKenna P., Kunz C., et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol 48 1 (1996) 102-107
27. Chiba N., Osada M., Komoro K., Mizutani T., Kariwa H., and Takashima I. Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization. Vaccine 17 11/2 (1999) 1532-1539
28. Zent O., Jilg W., Plentz A., Schwarz T.F., Fruhwein N., Kuhr H.B., et al. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule. Vaccine 21 32 (2003) 4655-4660
29. Zent O., Beran J., Jilg W., Mach T., and Banzhoff A. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine 21 7/8 (2003) 738-741
30. Beran J., Douda P., Gniel D., and Zent O. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 293 Suppl 37 (2004) 130-133
31. Rendi-Wagner P., Kundi M., Zent O., Banzhoff A., Jaehnig P., Stemberger R., et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 23 4 (2004) 427-434
32. Vene S., Haglund M., Vapalahti O., and Lundkvist A. A rapid fluorescent focus inhibition test for detection of neutralizing antibodies to tick-borne encephalitis virus. J Virol Meth 73 1 (1998) 71-75
33. Haglund M., Vene S., Forsgren M., Günther G., Johansson B., Niedrig M., et al. Characterisation of human tick-borne encephalitis virus from Sweden. J Med Virol 71 4 (2003) 610-621
34. Arneborn M, 2005. http://www.smittskyddsinstitutet.se/SMItemplates/Article.aspx?id=3130.
35. Kunze U., and Böhm G. Epidemiologic data on early summer meningoencephalitis and conclusions for a future approach including preventive early summer meningoencephalitis vaccination. Wien Med Wochenschr 148 8/9 (1998) 216-221
36. Kunze U., Bernhard G., Böhm G., and Groman E. Early-summer meningo-encephalitis (ESME) and ESME-vaccination: status 2000. Wien Med Wochenschr 150 5 (2000) 103-108
37. Guirakhoo F., Heinz F.X., Dippe H., and Kunz C. Antibody response to gp E of tick-borne encephalitis virus: comparison between natural infection and vaccination breakdown. Zentralbl Bakteriol 272 4 (1990) 477-484
38. Ecker M., Allison S.L., Meixner T., and Heinz F.X. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80 Pt 1 (1999) 179-185
39. Gustafson R., Forsgren M., Gardulf A., Granström M., and Svenungsson B. Clinical manifestations and antibody prevalence of Lyme borreliosis and tick-borne encephalitis in Sweden: a study in five endemic areas close to Stockholm. Scand J Infect Dis 25 5 (1993) 595-603
40. Kunz C. The impact on vaccination on TBE in Austria. Proceedings of the seventh Baltic-Nordic conference on tick-borne Zoonoses (2000)
41. Harabacz I., Bock H., Jungst C., Klockmann U., Praus M., and Weber R. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine 10 3 (1992) 145-150
42. Girgsdies O.E., and Rosenkranz G. Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine 14 15 (1996) 1421-1428
43. Zent O., Plentz A., Schwarz T.F., Fruhwein N., Kuhr H.B., Broeker M., et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?. Vaccine 23 3 (2004) 312-315
44. Rendi-Wagner P., Kundi M., Stemberger H., Wiedermann G., Holzmann H., Hofer M., et al. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 19 15/6 (2001) 2055-2060
45. Rendi-Wagner P., Kundi M., Zent O., Dvorak G., Jaehnig P., Holzmann H., et al. Persistence of protective immunity following vaccination against tick-borne encephalitis-longer than expected?. Vaccine 22 21/2 (2004) 2743-2749
46. Böttiger M. Polio immunity to killed vaccine: an 18-year follow-up. Vaccine 8 5 (1990) 443-445
47. Kaiser R. Inoculation against FSME (early summer meningoencephalitis)-a questionable use of antibody determination for checking the immunity status. Dtsch Med Wochenschr 124 17 (1999) 542
48. Treib J., Haass A., Kiessig S.T., Woessner R., Grauer M.T., and Schimrigk K. Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalence. Infection 24 5 (1996) 400-402
49. Rieger M., Neumann-Haefelin D., Gregersen J., Nübling M., and Hofmann F. Detection of antibodies against TBE virus by means of Western blot: confirmation of a high level of false positive ELISA results in a population with low TBE incidence. Zentralbl Bakteriol 289 (1999) 620-627
50. Kiessig S., Abel U., Risse P., Friedrich J., Heinz F., and Kunz C. Problems of cut-off level determination in enzyme immunoassays: the case of TBE-ELISA. Klin Lab 39 11 (1993) 877-886